article thumbnail

Eligo Bioscience Raises $30 Million To Write a Novel Chapter for Genetic Medicines

Digital Health Global

This infusion of capital, supported by new investor Bpifrance (through its InnoBio 2 fund), and existing backers Khosla Ventures and Seventure Partners (with Health For Life Capital ), propels Eligo towards becoming a clinical-stage biotech. Concurrent with this financing, Laia Crespo, Ph.D., Partner at Sanofi Ventures.

article thumbnail

Scotland's Pioneering Spirit: A Legacy of Medical and Healthcare Innovation

Lloyd Price

The biotech company is a spin-out of the University of Dundee and develops targeted protein degradation medicines, which have the potential to treat serious diseases that currently have limited treatments. These initiatives are helping to create a supportive environment for healthtech companies to thrive. "At

article thumbnail

A Matter of Trust, Perception, Risk, and Uncertainty – The Big Issues Raised by the Acquisition of PatientsLikeMe and Other Patient Data Transactions

Health Populi

When this occurred, it didn’t cause more than a ripple of interest outside biotech. Fear about an Ever-Changing Context : When PLM first formed back in 2004, a lot of the data sharing issues we speak about hadn’t even been conceived of yet. But the U.S. citizens’ personal data. Probably not so great.